| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |